MSOS Hits 2026 High as Trulieve Uplifts to NYSE on Wednesday, DEA Hearing Set for June 29

According to AdvisorShares, the Pure US Cannabis ETF (MSOS) hit its highest 2026 level as of June 5, delivering a 103.7% one-year net asset value (NAV) return and managing $1.13 billion in assets. The rally comes ahead of a June 29 DEA administrative hearing that will examine whether broader marijuana products, including adult-use cannabis, should move to Schedule III.

Triulieve Cannabis, MSOS' largest holding at 30% of assets, is set to begin trading on the NYSE under the symbol TRLV on Wednesday following its restructuring to focus on medical cannabis operations. The listing follows April's Schedule III reclassification of state-licensed medical marijuana, which eliminated key tax penalties for licensed operators and improved capital access and banking services across the sector.